Navigation Links
Daytrana in Medical News

New analysis shows DAYTRANA offered ADHD symptom control for 12 months

Washington, D.C. May 7, 2008 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA (methylphenidate transdermal system) between boys and girls aged 6...

Long-term 12-month safety data on ADHD patch DAYTRANA

BOSTON OCTOBER 25, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that data from a 12-month study of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRA...

Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom

DAYTRANA (methylphenidate transdermal system), formulated by Shire was the foremost patch medication approved to treat symptoms of ADHD in children//. Transdermal formulation of methylphenidate - DAYTRANA, is now available in pharmacies in varying doses such as 10 mg, 15 mg, 20 mg and 30 mg. ...

Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced

.../recall of thirty-nine (39) lots of the ADHD patch daytrana (the lots of daytrana patches affected by this action are listed below). Shire is taking this action because some daytrana patches no longer meet their release liner removal...

Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track

... 10.6(3) n/a n/a 2% daytrana 9.4 -5% 64% ...to be recognized into revenue by the end of 2007. daytrana - ADHD DAYTRANA's average share of the US ADHD ma...the US ADHD market resulted in US prescriptions of daytrana for the three months to September 30, 2007 being u...

Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting

...e Effect Size in Children with ADHD Poster# E58 daytrana (methylphenidate transdermal system): October 25...Information go to http://www.vyvanse.com . About daytrana Tell your doctor about any heart conditions, incl...t heart problems, such as chest pain or fainting. daytrana should not be used if the child has: significant a...
Daytrana in Medical Technology

Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)

...m) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). A request from European regulators to conduct an additional clinical study on daytrana in a European patient population combined with the recently announced planned acquisition of the worldwide rights (excluding the US, Canada and Barbad...

New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months

...D). The findings from the analysis reaffirmed that daytrana has an established safety profile and effectively ...n, D.C. "This analysis further demonstrates that daytrana has a recognized safety profile and is an effectiv... decreased weight. In the study, the efficacy of daytrana was measured using the ADHD Rating Scale (ADHD-RS-...

Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)

...ractivity Disorder (ADHD) patch, demonstrated that daytrana provided significant ADHD tolerability and symptom...ective ADHD symptom control improvement when using daytrana for 12 months, improving their ability to maintain...a. "Importantly, this year- long study showed that daytrana maintained a favorable safety profile throughout t...

Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting

...ctivity Disorder APA Poster# NR750 daytrana (methylphenidate transdermal system): May 23...tite, insomnia, headache, and weight loss. About daytrana daytrana should not be used in patients with allergy to met...

12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

...D experienced effective ADHD treatment with use of daytrana for 12 months, sustaining the improvements in thei... Pittsburgh School of Medicine. "More importantly, daytrana maintained a favorable safety profile, meeting the... and other stimulants in this class." Shire's daytrana is the first and only patch medication approved by...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

...agnosed and, therefore, undertreated. Shire's daytrana is the first and only patch medication approved by...e symptoms of ADHD in children aged 6 to 12 years. daytrana is available in four dosage strengths - 10 mg, 15 ...dy's primary endpoint. The 58 boys that received daytrana averaged a significant 56 percent ADHD- RS-IV tota...
Daytrana in Biological Technology

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... 67.4 -77% -77% -48% 11.0% daytrana 14.9 -34% -34% ...ADDERALL XR to Teva in the URA calculation. daytrana - ADHD Product sales of daytrana for the three months to June 30, 2009 decreased by...

Shire begins the year with a strong performance

...-promotion of LIALDA in the US. Pipeline daytrana - for the treatment of ADHD in children in the EU ...he MAA does not impact Shire's commitment to daytrana in the US where the product has been used as...the US in the fourth quarter of 2009; - daytrana for the treatment of ADHD in adolescents in the US...

Publication of Shire plc's Annual Report 2008

...VANT in certain EU countries; - the launch of daytrana (EU and Canada); - the continued roll out of ...oval; six in the US (FOSRENOL and EQUETRO in 2004, daytrana and ELAPRASE in 2006, LIALDA and VYVANSE in 2007) ...atory filing for VYVANSE in Europe in 2010. daytrana for ADHD in EU & Canada Regulatory subm...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ucting additional clinical outcomes trials; - daytrana (methylphenidate transdermal system) for use in th... 318.9 +317% +388% 8.2% daytrana 78.7 +23% -11% ...n 2007) and a price increase in April 2008. daytrana - ADHD Product sales for the year to Decemb...

Shire's New Product Portfolio Delivers Strong Quarterly Performance

... 96.0 806% n/a 9.0% daytrana 18.1 93% -14% ... of 10.2%, based on weekly prescription volumes. daytrana - ADHD Product sales for the three months to Sep... of DAYTRANA. No interruption in the production of daytrana is anticipated. Shire and Noven may take additiona...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... 65.2 n/a n/a 7.4% daytrana 22.6 14% -11% ...re of 8.2% based on weekly prescription volumes. daytrana - ADHD Product sales for the three months to Jun...nounced a voluntary recall of a limited portion of daytrana patches because certain patches did not meet their...

Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced

...voluntary recall of two (2) lots of the ADHD patch daytrana (lots 2750211 and 2764111). Shire is taking this a...while being opened. The current supply levels of daytrana should be sufficient to ensure that patients can continue to have their daytrana prescriptions filled at their local pharmacy. Nove...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

...have difficulty removing the release liner of some daytrana patches, similar to the concerns which led to a voluntary market withdrawal of a limited number of daytrana patches in September 2007. Shire and Noven continu...for use in adult patients in the US in Q2 2008; - daytrana in the EU during H1 2009; - INTUNIV in the US dur...

Shire plc: IFRS Results for the Year Ending December 31, 2007

... 76.5 - N/A N/A daytrana 64.2 25.1 +156 +...to revenue during the year to December 31, 2007. daytrana - ADHD Product sales for the year to December 31...NA was launched in June 2006). US prescriptions of daytrana for the year to December 31, 2007 over 2006 benefi...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

...nto new geographies. These products, together with daytrana that was launched last year, represented 32% of ou... patients, of which 7.5 million are untreated. - daytrana - ADHD - Regulatory submissions were filed for app...US in Q2 2008 (PDUFA date April 28, 2008); - daytrana in the EU during H1 2009; - INTUNIV in the US dur...
Other Tags
(Date:9/17/2014)... TX (PRWEB) September 17, 2014 North ... were recently granted several awards for their top-notch services. ... patient experience, orthopedic care and GYN surgery. , Hospital-wide, ... Safety Excellence Award™. They have received this award for ... among the top 5 percent in the nation for ...
(Date:9/17/2014)... (HealthDay News) -- A blood test that measures DNA ... a better assessment of the state of a man,s ... routinely, this blood test could reveal when treatment ... promoting tumor growth, the researchers suggested. "Our study ... advanced prostate cancer and often initially very effective started ...
(Date:9/17/2014)... New York, New York (PRWEB) September 17, 2014 ... ) filings involving the Conserve line of metal-on-metal ... litigation now underway in U.S. District Court, Northern ... to an updated Case List issued by the ... 15, 2014, at least 397 product liability claims ...
(Date:9/17/2014)... Why are Asian Americans at higher risk of developing ... develop the disease at lower body weights? One part ... traditional high-fiber, low-fat Asian diets to current westernized diets, ... heritage, says George King, M.D., Senior Vice President and ... senior author of the study. , A Joslin randomized ...
(Date:9/17/2014)... The in vitro diagnostics (IVD) marketplace is ... on molecular diagnostics for conditions such as infectious diseases, ... IVD market value is projected to be worth around ... major drivers of the market’s growth include the shift ... by the explosion for raid and minimally-invasive diagnostic tools; ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center Receives Several Accolades 2Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 2Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 3Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 3
(Date:9/17/2014)... State,s Institute for the Arts and Humanities has received ... for a two-year project, "The Boundaries of the Human ... project will support a wide-ranging series of events aimed ... humanities. One involves artists and researchers who are exploring ... the idea of humanism, and the other involves the ...
(Date:9/17/2014)... (Sept. 17, 2014) A rare genetic disorder known as ... a recent joint investigation by researchers at San Diego ... In addition to suggesting better treatment options for people ... into the genetic underpinnings of autism., Jacobsen syndrome affects ... Institutes of Health. It occurs in a person when ...
(Date:9/17/2014)... the Copenhagen Centre for Social Evolution and Yale University ... birth weight and -length can partially predict the likelihood ... autism and schizophrenia later in life. The study analyzed ... hospital diagnoses for up to 30 years, and adjusted ... is published today in the Proceedings of the ...
Breaking Biology News(10 mins):Mellon Foundation awards grant for major project in the humanities and sciences 2A link between Jacobsen syndrome and autism 2Size at birth affects risk of adolescent mental health disorders 2Size at birth affects risk of adolescent mental health disorders 3
Other Contents